Demographic aspects |
Variable age at onset (range 13–87, median value 53 years) |
No gender predilection |
Clinical history |
Mostly non-smokers |
Recurrent pulmonary infections |
Familial background of interstitial lung disease |
Symptoms |
Dry cough |
Exertional dyspnea |
Chronic dull pleuritic pain (occasionally sharp) |
Weight loss |
Signs |
“Flattened” thoracic cage (or “plathythorax”) |
Slender habitus |
Bibasal crackles, if usual interstitial pneumonia (UIP)-like changes in lower lobes |
Functional parameters |
Restrictive ventilatory impairment: disproportionate reduction in forced vital capacity (FVC) compared to diffusing capacity of carbon monoxide (DLCO), with KCO (DLCO/VA) trends towards supernormal values |
Increased ratio of residual volume/total lung capacity (RV/TLC) |
Gas analysis |
Earlier stages: normal pressure of oxygen (Pa O2), with mild increase in the partial pressure of carbon dioxide (PCO2), with a preserved alveolar-arterial gradient of oxygen (A-aDO2) |
Advanced stages: hypoxemia with hypercapnic respiratory failure |
Serum biomarkers |
Elevated surfactant protein D (SP-D) |
Normal Krebs von den Lungen-6 (KL-6), or slightly increased in advanced stage |
Increased titres of a variety of serum auto-antibodies |
Imaging features |
Upper lobe bilateral, irregular pleural thickening, and dense reticular fibrosis of subjacent lung parenchyma |
Clear demarcation between abnormal and normal lung |
Hila retracted upwards with distortion of the lung architecture |
Overall volume loss and reduced ratio of the anteroposterior to the transverse diameter |
Interlobular septal thickening, small foci of consolidation, large cysts, and multiple bullae may be observed |
Uni- or bilateral pneumothoraces may occur |
Coexistent interstitial involvement of the lower lobes (usually UIP-like changes) in a proportion of cases |
Pathologic findings |
Fibrous thickening of the visceral pleura with elastic fibers |
Homogeneous, dense, intra-alveolar fibrosis with septal elastosis (twice that observed in idiopathic pulmonary fibrosis) |
Transition from abnormal lesions to normal tissue typically abrupt |
Mild, sparse mononuclear lymphocytic infiltration |
Sparse fibroblastic foci |
Partial stenosis of pulmonary vessels, both arterial and venous |